Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference

Yahoo Finance
Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference
Ascendis Pharma A/S (NASDAQ:ASND) highlighted accelerating product revenue growth, expanding international commercialization, and multiple 2026 cli...